3',4'-O-DIDEMETHYL-1-BETA CARBOXYLATED HYDROGENATED ISTRADEFYLLINE
UNII G2E7E4E4HK

Substance Identification & Data

This profile provides standardized clinical and technical data for 3',4'-o-didemethyl-1-beta Carboxylated Hydrogenated Istradefylline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G2E7E4E4HK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

G2E7E4E4HK

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

3',4'-O-DIDEMETHYL-1-BETA CARBOXYLATED HYDROGENATED ISTRADEFYLLINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H20N4O6

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

NKPZRHCJXMKGNT-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

145721986

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12c(c(=O)n(c(n1CC)=O)CC(O)=O)n(C)c(n2)CCc3cc(O)c(cc3)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3',4'-o-didemethyl-1-beta Carboxylated Hydrogenated Istradefylline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.